Insider Trading
Track Major Insider Updates On X/Twitter
GNLX Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on GNLX stock insider trading activity, which can give hints on whether Genelux Corp executives are bullish or bearish on their own company.
Recent insider purchases and sales - GNLX
Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
Tyree James L
|
Sale | 3460 | Dec 30, 2024 | Dec. 30, 2024, 8:48 p.m. |
Zindrick Thomas
President and CEO
|
Sale | 14315 | Dec 16, 2024 | Dec. 18, 2024, 5:35 p.m. |
Zak Lourie S.
Chief Financial Officer
|
Sale | 2103 | Dec 16, 2024 | Dec. 18, 2024, 5:35 p.m. |
Smalling Ralph
Head of Regulatory
|
Sale | 2510 | Dec 16, 2024 | Dec. 18, 2024, 5:35 p.m. |
Cappello Joseph
VP, Pharmaceutical Development
|
Sale | 6300 | Dec 16, 2024 | Dec. 18, 2024, 5:35 p.m. |
Szalay Aladar
|
Sale | 33080 | Sep 13, 2024 | Sept. 13, 2024, 6:22 p.m. |
Szalay Aladar
|
Sale | 31777 | Sep 12, 2024 | Sept. 13, 2024, 6:22 p.m. |
Tyree James L
|
Sale | 1730 | Sep 11, 2024 | Sept. 12, 2024, 8:40 p.m. |
Szalay Aladar
|
Sale | 31376 | Sep 11, 2024 | Sept. 11, 2024, 6:23 p.m. |
Szalay Aladar
|
Sale | 23383 | Sep 09, 2024 | Sept. 11, 2024, 6:23 p.m. |
Szalay Aladar
|
Sale | 20384 | Sep 10, 2024 | Sept. 11, 2024, 6:23 p.m. |
Szalay Aladar
|
Sale | 42818 | Sep 03, 2024 | Sept. 6, 2024, 5:08 p.m. |
Szalay Aladar
|
Sale | 142589 | Aug 30, 2024 | Aug. 30, 2024, 7:58 p.m. |
Szalay Aladar
|
Sale | 15918 | Aug 28, 2024 | Aug. 30, 2024, 7:58 p.m. |
Szalay Aladar
|
Sale | 107045 | Aug 29, 2024 | Aug. 30, 2024, 7:58 p.m. |
Szalay Aladar
|
Sale | 40000 | Aug 23, 2024 | Aug. 27, 2024, 7:23 p.m. |
Szalay Aladar
|
Sale | 51630 | Aug 27, 2024 | Aug. 27, 2024, 7:23 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Sale | 6849 | Jun 24, 2024 | July 8, 2024, 4:30 p.m. |
Ryder Sean
General Counsel
|
Sale | 5496 | Jun 24, 2024 | July 8, 2024, 4:30 p.m. |
Jewett Caroline
Head of Quality
|
Sale | 4961 | Jun 24, 2024 | July 8, 2024, 4:30 p.m. |
Tyree James L
|
Purchase | 6250 | May 29, 2024 | June 7, 2024, 9:45 p.m. |
Smither John W
|
Purchase | 6250 | May 29, 2024 | June 7, 2024, 9:45 p.m. |
Thomas John
|
Purchase | 2500 | May 29, 2024 | June 7, 2024, 9:45 p.m. |
Mirabelli Mary
|
Purchase | 8000 | May 29, 2024 | June 7, 2024, 9:45 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Purchase | 2500 | May 29, 2024 | June 7, 2024, 9:40 p.m. |
Zindrick Thomas
President and CEO
|
Purchase | 200000 | May 29, 2024 | June 7, 2024, 9:40 p.m. |
Smalling Ralph
Head of Regulatory
|
Purchase | 1250 | May 29, 2024 | June 7, 2024, 9:40 p.m. |
Ryder Sean
General Counsel
|
Purchase | 10000 | May 29, 2024 | June 7, 2024, 9:40 p.m. |
Zak Lourie S.
Chief Financial Officer
|
Purchase | 31250 | May 29, 2024 | June 7, 2024, 9:40 p.m. |
Szalay Aladar
|
Sale | 15426 | May 14, 2024 | May 15, 2024, 5:59 p.m. |
Szalay Aladar
|
Sale | 3446 | May 13, 2024 | May 15, 2024, 5:59 p.m. |
Szalay Aladar
|
Sale | 17094 | May 15, 2024 | May 15, 2024, 5:59 p.m. |
Szalay Aladar
|
Sale | 13919 | May 08, 2024 | May 9, 2024, 4:38 p.m. |
Szalay Aladar
|
Sale | 6025 | May 07, 2024 | May 9, 2024, 4:38 p.m. |
Szalay Aladar
|
Sale | 20535 | Apr 30, 2024 | May 1, 2024, 6:16 p.m. |
Szalay Aladar
|
Sale | 6403 | Apr 29, 2024 | May 1, 2024, 6:16 p.m. |
Szalay Aladar
|
Sale | 33061 | May 01, 2024 | May 1, 2024, 6:16 p.m. |
Szalay Aladar
|
Sale | 14331 | Apr 22, 2024 | April 24, 2024, 5:50 p.m. |
Szalay Aladar
|
Sale | 22000 | Apr 23, 2024 | April 24, 2024, 5:50 p.m. |
Szalay Aladar
|
Sale | 8064 | Apr 24, 2024 | April 24, 2024, 5:50 p.m. |
Szalay Aladar
|
Sale | 48683 | Apr 16, 2024 | April 18, 2024, 5 p.m. |
Szalay Aladar
|
Sale | 22737 | Apr 17, 2024 | April 18, 2024, 5 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Sale | 5803 | Dec 15, 2023 | Dec. 18, 2023, 5:15 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Sale | 26732 | Dec 15, 2023 | Dec. 18, 2023, 5:15 p.m. |
Tyree James L
|
Sale | 5653 | Dec 13, 2023 | Dec. 14, 2023, 9:59 p.m. |
Tyree James L
|
Sale | 3347 | Dec 13, 2023 | Dec. 14, 2023, 9:59 p.m. |
Thomas John
|
Sale | 7073 | Dec 13, 2023 | Dec. 14, 2023, 9:58 p.m. |
Thomas John
|
Sale | 1927 | Dec 13, 2023 | Dec. 14, 2023, 9:58 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Sale | 36800 | Dec 07, 2023 | Dec. 8, 2023, 6:57 p.m. |
Yu Yong
VP, Clinical Trial Operations
|
Sale | 18665 | Nov 21, 2023 | Nov. 22, 2023, 5:15 p.m. |